What is the level of liabilities of Orion Nutraceuticals this year?
Orion Nutraceuticals has a debt balance of 644,680.02 CAD this year.
In 2024, Orion Nutraceuticals's total liabilities amounted to 644,680.02 CAD, a 43.79% difference from the 448,360 CAD total liabilities in the previous year.
Orion Nutraceuticals's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Orion Nutraceuticals's financial stability, operational efficiency, and long-term viability.
By comparing Orion Nutraceuticals's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Orion Nutraceuticals's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Shifts in Orion Nutraceuticals’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Orion Nutraceuticals has a debt balance of 644,680.02 CAD this year.
The liabilities of Orion Nutraceuticals have increased by 43.79% increased compared to the previous year.
High liabilities can pose a risk for investors of Orion Nutraceuticals, as they can weaken the company's financial position and impair its ability to meet its obligations.
Low liabilities mean that Orion Nutraceuticals has a strong financial position and is able to meet its obligations without overburdening its finances.
An increase in liabilities of Orion Nutraceuticals can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
A decrease in the liabilities of Orion Nutraceuticals can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
Some factors that can influence the liabilities of Orion Nutraceuticals include investments, acquisitions, operating costs, and sales development.
The liabilities of Orion Nutraceuticals are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
To change its liabilities, Orion Nutraceuticals can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
Over the past 12 months, Orion Nutraceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Orion Nutraceuticals is expected to pay a dividend of 0 CAD.
The current dividend yield of Orion Nutraceuticals is .
Orion Nutraceuticals pays a quarterly dividend. This is distributed in the months of .
Orion Nutraceuticals paid dividends every year for the past 0 years.
For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.
Orion Nutraceuticals is assigned to the '-' sector.
To receive the latest dividend of Orion Nutraceuticals from 9/29/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 9/29/2024.
The last dividend was paid out on 9/29/2024.
In the year 2023, Orion Nutraceuticals distributed 0 CAD as dividends.
The dividends of Orion Nutraceuticals are distributed in CAD.
Our stock analysis for Orion Nutraceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Orion Nutraceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.